Conclusions:
These findings reveal that sirtuins take part in cellular responses during glaucomatous neurodegeneration and motivate further research to determine the importance of sirtuins and the therapeutic potential of sirtuin modulators for neurodegenerative and neuroinflammatory outcomes in glaucoma.